MetLife Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,033
Closed -$20.7K 2895
2025
Q1
$20.7K Sell
2,033
-5,067
-71% -$51.7K ﹤0.01% 2747
2024
Q4
$99.1K Hold
7,100
﹤0.01% 2628
2024
Q3
$138K Buy
7,100
+4,000
+129% +$78K ﹤0.01% 2473
2024
Q2
$57.7K Buy
+3,100
New +$57.7K ﹤0.01% 2737
2023
Q2
Sell
-4,057
Closed -$42.8K 2971
2023
Q1
$42.8K Sell
4,057
-2,279
-36% -$24K ﹤0.01% 2728
2022
Q4
$215K Hold
6,336
﹤0.01% 2206
2022
Q3
$304K Hold
6,336
﹤0.01% 2011
2022
Q2
$361K Buy
6,336
+6,097
+2,551% +$348K ﹤0.01% 1885
2022
Q1
$19.4K Buy
+239
New +$19.4K ﹤0.01% 2710
2021
Q4
Sell
-5,887
Closed -$1.59M 2534
2021
Q3
$1.59M Sell
5,887
-186
-3% -$50.1K 0.01% 946
2021
Q2
$1.56M Sell
6,073
-201
-3% -$51.7K 0.01% 964
2021
Q1
$1.88M Sell
6,274
-271
-4% -$81.3K 0.02% 891
2020
Q4
$1.67M Sell
6,545
-283
-4% -$72.2K 0.02% 914
2020
Q3
$1.7M Sell
6,828
-219
-3% -$54.5K 0.02% 788
2020
Q2
$2.45M Buy
7,047
+315
+5% +$109K 0.03% 632
2020
Q1
$1.8M Hold
6,732
0.02% 653
2019
Q4
$2.18M Buy
6,732
+3,552
+112% +$1.15M 0.02% 775
2019
Q3
$869K Sell
3,180
-23
-0.7% -$6.28K 0.01% 1139
2019
Q2
$1.71M Sell
3,203
-95
-3% -$50.7K 0.02% 880
2019
Q1
$1.66M Hold
3,298
0.02% 888
2018
Q4
$1.63M Sell
3,298
-45
-1% -$22.2K 0.02% 841
2018
Q3
$3.06M Buy
3,343
+181
+6% +$166K 0.03% 657
2018
Q2
$2.32M Sell
3,162
-4,530
-59% -$3.32M 0.03% 742
2018
Q1
$12.3M Buy
7,692
+3,228
+72% +$5.15M 0.14% 132
2017
Q4
$4M Buy
+4,464
New +$4M 0.05% 469